Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Preferred Shares Issued (2020 - 2021)

Historic Preferred Shares Issued for Design Therapeutics (DSGN) over the last 2 years, with Q1 2021 value amounting to $124.7 million.

  • Design Therapeutics' Preferred Shares Issued rose 17880.44% to $124.7 million in Q1 2021 from the same period last year, while for Dec 2021 it was $124.7 million, marking a year-over-year increase of 17880.44%. This contributed to the annual value of $124.7 million for FY2021, which is 17880.44% up from last year.
  • Design Therapeutics' Preferred Shares Issued amounted to $124.7 million in Q1 2021, which was up 17880.44% from $44.7 million recorded in Q1 2020.
  • In the past 5 years, Design Therapeutics' Preferred Shares Issued ranged from a high of $124.7 million in Q1 2021 and a low of $44.7 million during Q1 2020